Talis Biomedical Corp (TLIS)
8.91
-0.08
(-0.94%)
USD |
NASDAQ |
Jun 14, 16:00
8.95
+0.04
(+0.45%)
After-Hours: 20:00
Talis Biomedical Total Liabilities (Quarterly): 25.81M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 25.81M |
December 31, 2023 | 25.56M |
September 30, 2023 | 25.67M |
June 30, 2023 | 26.91M |
March 31, 2023 | 22.93M |
December 31, 2022 | 42.55M |
September 30, 2022 | 41.71M |
June 30, 2022 | 44.67M |
Date | Value |
---|---|
March 31, 2022 | 27.80M |
December 31, 2021 | 31.85M |
September 30, 2021 | 44.30M |
June 30, 2021 | 85.81M |
March 31, 2021 | 46.85M |
December 31, 2020 | 306.98M |
September 30, 2020 | 181.19M |
December 31, 2019 | 46.87M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
22.93M
Minimum
Mar 2023
306.98M
Maximum
Dec 2020
64.22M
Average
42.13M
Median
Total Liabilities (Quarterly) Benchmarks
Perspective Therapeutics Inc | 48.40M |
Retractable Technologies Inc | 76.32M |
Xtant Medical Holdings Inc | 46.25M |
Asensus Surgical Inc | 27.79M |
Catheter Precision Inc | 9.497M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 82.49M |
Shareholders Equity (Quarterly) | 56.68M |
Current Ratio | 7.514 |